Interleukins and cytokine biomarkers in uveitis
- PMID: 32823391
- PMCID: PMC7690463
- DOI: 10.4103/ijo.IJO_564_20
Interleukins and cytokine biomarkers in uveitis
Abstract
Interleukins and cytokines are involved in the pathogenesis of uveitis of heterogeneous origin. Understanding the basics of the ocular immune privilege is a fulcrum to discern their specific role in diverse uveitis to potentially translate as therapeutic targets. This review attempts to cover these elements in uveitis of infectious, noninfectious and masquerade origin. Insights of the molecular targets in novel therapy along with the vision of future research are intriguing.
Keywords: Biologicals; chemokines; interleukins; masquerades.
Conflict of interest statement
None
Figures
References
-
- Saxena S, Srivastav K. Biologic response modifiers in retinal vasculitis. World J Immunol. 2014;4:122–9.
-
- Rathinam SR, Namperumalsamy P. Global variation and pattern changes in epidemiology of uveitis. Indian J Opthalmol. 2007;55:173–83. - PubMed
-
- Scharf Y, Zonis S. Histocompatibility antigens (HLA) and uveitis. Surv Ophthalmol. 1980;24:220–8. - PubMed
-
- Ferguson TA, Fletcher S, Herndon J, Griffith TS. Neuropeptides modulate immune deviation induced via the anterior chamber of the eye. J Immunol. 1995;155:1746–56. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
